We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$2.7B
1-Year Est. Return
29.67%
This Fund
S&P 500
This Quarter
Est. Return
+10.93%
1 Year Est. Return
+29.67%
3 Year Est. Return
+102.72%
5 Year Est. Return
+136.36%
10 Year Est. Return
+453.01%
AUM
$1.29B
AUM Growth
+$111M
(+9.4%)
Cap. Flow
+$4.96M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
40.89%
Holding
336
New
25
Increased
101
Reduced
44
Closed
22
Top Buys
| 1 |
AbbVie
ABBV
|
+$4.14M |
| 2 |
Amgen
AMGN
|
+$2.76M |
| 3 |
JD.com
JD
|
+$730K |
| 4 |
LKQ Corp
LKQ
|
+$723K |
| 5 |
Ulta Beauty
ULTA
|
+$628K |
Top Sells
| 1 |
ExxonMobil
XOM
|
+$4.35M |
| 2 |
Teleflex
TFX
|
+$1.59M |
| 3 |
TransUnion
TRU
|
+$1.05M |
| 4 |
Chevron
CVX
|
+$834K |
| 5 |
Bio-Techne
TECH
|
+$513K |
Sector Composition
| 1 | Technology | 26.06% |
| 2 | Industrials | 14.15% |
| 3 | Communication Services | 14.09% |
| 4 | Consumer Discretionary | 11.33% |
| 5 | Healthcare | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
126
Novo Nordisk
NVO
$217B
| $668K | 0.05% |
19,242
+5,236
| +37% | +$175K |
|
127
Southern Company
SO
$108B
| $666K | 0.05% |
12,288
| – | – |
|
128
Cigna
CI
$80.2B
| $648K | 0.05% |
3,825
| – | – |
|
129
Eaton
ETN
$161B
| $636K | 0.05% |
6,231
+43
| +0.7% | +$4.2K |
|
130
Frontdoor
FTDR
$5.23B
| $619K | 0.05% |
15,901
-8,443
| -35% | -$360K |
|
131
Duke Energy
DUK
$98.5B
| $617K | 0.05% |
6,968
+79
| +1% | +$6.51K |
|
132
Donaldson
DCI
$10.4B
| $606K | 0.05% |
13,061
+54
| +0.4% | +$2.63K |
|
133
iShares MSCI Japan ETF
EWJ
$22.4B
| $606K | 0.05% |
10,251
| – | – |
|
134
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.76B
| $604K | 0.05% |
25,100
| – | – |
|
135
Kirby Corp
KEX
$7.76B
| $601K | 0.05% |
16,609
-4,089
| -20% | -$180K |
|
136
Accenture
ACN
$82.3B
| $600K | 0.05% |
2,653
-563
| -18% | -$129K |
|
137
Natera
NTRA
$39B
| $600K | 0.05% |
8,299
-1,704
| -17% | -$96.9K |
|
138
Infosys
INFY
$44.7B
| $599K | 0.05% |
43,352
+436
| +1% | +$5.44K |
|
|
UN
139
DELISTED
Unilever NV New York Registry Shares
UN
| $584K | 0.05% |
9,665
+37
| +0.4% | +$2.14K |
|
140
Trane Technologies
TT
$107B
| $578K | 0.04% |
4,766
+19
| +0.4% | +$2.13K |
|
141
Citigroup
C
$227B
| $562K | 0.04% |
13,034
+126
| +1% | +$6.28K |
|
142
Chubb
CB
$134B
| $556K | 0.04% |
4,791
+864
| +22% | +$109K |
|
143
Illinois Tool Works
ITW
$78.3B
| $545K | 0.04% |
2,821
-490
| -15% | -$93.1K |
|
144
Takeda Pharmaceutical
TAK
$52.3B
| $542K | 0.04% |
30,391
| – | – |
|
145
Philips
PHG
$25.3B
| $521K | 0.04% |
13,623
+270
| +2% | +$10.8K |
|
146
Fresenius Medical Care
FMS
$13B
| $515K | 0.04% |
12,122
+2,149
| +22% | +$92.7K |
|
147
Sally Beauty Holdings
SBH
$1.37B
| $511K | 0.04% |
58,825
| – | – |
|
148
Henry Schein
HSIC
$9.9B
| $509K | 0.04% |
8,652
| – | – |
|
149
Sanofi
SNY
$103B
| $503K | 0.04% |
10,023
| – | – |
|
150
AstraZeneca
AZN
$255B
| $503K | 0.04% |
4,587
| – | – |
|
Similar funds
TPSF
CI
GIA
PCM
SFS
HCM
NB
WGI